Contact us for information on our 4-step SARS-CoV-2 research sequencing panel
Check out our poster on SARS-CoV-2 sequencing at AGBT 2021!
Founded by NGS experts with deep roots in high-throughput clinical testing, Molecular Loop offers a no-compromise solution for production-scale targeted sequencing applications.
Tired of having to choose between throughput and high-quality results?
Now you don’t have to.
High-quality variant and copy number calls
Custom panels that don’t require optimization
Don’t make a major automation investment to scale up a hybrid capture process without talking to us first. If you’re just getting started with targeted NGS, our technology will lower barriers and get you up and running faster.
Our patented technology was developed through years of experience with next-generation sequencing-based clinical applications. Our goal was to combine the simplicity and throughput of amplicon-based workflows with the high data quality of hybrid capture libraries. Molecular Loop’s targeting chemistry does just that.
Molecular Loop and The Molecular Loop logo are trademarks of Molecular Loop Biosciences, Inc.
© 2020 Molecular Loop Biosciences, Inc. All rights reserved.